Ubs Group Ag Axcella Health Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.22 - $0.46 $1,169 - $2,445	-5,317 Reduced 85.52%	900 $0
Q1 2023 May 12, 2023	BUY	$0.31 - $0.77 $1,927 - $4,787	6,217 New	6,217 $2,000
Q3 2022 Nov 10, 2022	SELL	$1.62 - $2.73 $3,907 - $6,584	-2,412 Reduced 43.5%	3,133 $5,000
Q2 2022 Aug 10, 2022	BUY	$1.41 - $2.77 $3,395 - $6,670	2,408 Added 76.76%	5,545 $11,000
Q1 2022 May 16, 2022	BUY	$1.58 - $2.82 $2,039 - $3,640	1,291 Added 69.93%	3,137 $8,000
Q4 2021 Feb 14, 2022	SELL	$2.06 - $3.61 $7,813 - $13,692	-3,793 Reduced 67.26%	1,846 $4,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $3,355 - $4,853	-1,126 Reduced 16.64%	5,639 $16,000
Q2 2021 Aug 13, 2021	SELL	$3.08 - $5.13 $2,941 - $4,899	-955 Reduced 12.37%	6,765 $27,000
Q1 2021 May 12, 2021	BUY	$4.55 - $6.72 $21,708 - $32,061	4,771 Added 161.78%	7,720 $37,000
Q4 2020 Feb 11, 2021	BUY	$4.24 - $5.97 $6,678 - $9,402	1,575 Added 114.63%	2,949 $15,000
Q3 2020 Nov 12, 2020	SELL	$4.12 - $5.91 $7,214 - $10,348	-1,751 Reduced 56.03%	1,374 $6,000
Q2 2020 Jul 31, 2020	SELL	$2.94 - $7.7 $17,425 - $45,637	-5,927 Reduced 65.48%	3,125 $17,000
Q1 2020 May 01, 2020	SELL	$2.25 - $5.24 $22,547 - $52,510	-10,021 Reduced 52.54%	9,052 $31,000
Q4 2019 Feb 14, 2020	BUY	$3.08 - $5.9 $54,112 - $103,657	17,569 Added 1168.15%	19,073 $76,000
Q3 2019 Nov 14, 2019	SELL	$5.25 - $9.26 $756 - $1,333	-144 Reduced 8.74%	1,504 $9,000
Q2 2019 Aug 14, 2019	BUY	$8.51 - $14.95 $14,024 - $24,637	1,648 New	1,648 $15,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.